Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Patients With Septic Shock
NCT00450840Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of simvastatin in septic shock, sponsored by Medical University of Vienna. Primary endpoint: Time to shock reversal. Status: unknown.
02
Drugs
simvastatin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00450840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450840.